Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark mice

Journal of Biomedical Science(2024)10.1186/s12929-024-01025-6Source: DataRank Database

Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark mice is a research paper published in Journal of Biomedical Science (2024). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

Linked data & code

bioproject doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 5.30)OA: goldTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Kuan-Yin Tseng,Tung‐Tai Kuo ORCID,Eagle Yi‐Kung Huang,Kuo-Lun Lan,Zirong Chen ORCID

Live enrichment

PubMed:38627765 PMC:PMC11022395 OpenAlex:https://openalex.org/W4394869555

Tri-Service General Hospital

Grant: TSGH-D-112095

Tri-Service General Hospital

Grant: TSGH-C01-112024

Ministry of Science and Technology, Taiwan

Grant: MOST 109-2314-B-016 -019 -MY2

Ministry of Science and Technology, Taiwan

Grant: MOST 111-2314-B-016-057

Ministry of Science and Technology, Taiwan

Grant: NSTC 112-2314-B-016 -068 -MY3

National Defense Medical Center

Grant: MAB_D_112004

National Defense Medical Center

Grant: MND-MAB-C05-112019

National Institute on Aging

Grant: AG000333

Technological Innovation R&D Program

Grant: S2174574

Bio and Medical Technology Development Program

Grant: NRF-2014M3A9B5073868

National Institutes of Health

Grant: 1ZIAAG000333-15

Neuroprotective role of GLP-1 receptor agonists (Neurodegenerative disorders & Alzheimer's disease)

FWCI

5.30

Citation Percentile

1.0%

Influential Citations

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://jbiomedsci.biomedcentral.com/counter/pdf/10.1186/s12929-024-01025-6

GOLDhttps://jbiomedsci.biomedcentral.com/counter/pdf/10.1186/s12929-024-01025-6

publisherhttps://jbiomedsci.biomedcentral.com/counter/pdf/10.1186/s12929-024-01025-6

publisherhttps://link.springer.com/content/pdf/10.1186/s12929-024-01025-6.pdf

publisherhttps://link.springer.com/article/10.1186/s12929-024-01025-6/fulltext.html

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsDiabetes Treatment and ManagementAdipose Tissue and MetabolismMedicineBiology0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

ExenatideGlucagon-Like Peptide-1 Receptor AgonistsAnimalsDisease Models, AnimalDopamineMitochondriaParkinson DiseaseMitochondrial DiseasesCytochromes cMice

Keywords

Mitochondrionmitochondrial fusionCell biologyTyrosine hydroxylaseBiologyFIS1Mitochondrial fissionNeuroprotectionDopaminergicAgonistEndocrinologyInternal medicinePharmacologyReceptorDopamineMedicineBiochemistryMitochondrial DNAMitochondriaParkinson’s DiseaseExenatideGlucagon-like Peptide-1 Receptor AgonistMitopark MousePt320Mitochondrial DiseasesResearchRCytochromes cParkinson DiseaseDisease Models, AnimalGlucagon-Like Peptide-1 Receptor Agonists

Sustainable Development Goals

SDG 0: Affordable and clean energy